Financhill
Buy
68

MDGL Quote, Financials, Valuation and Earnings

Last price:
$603.30
Seasonality move :
15.11%
Day range:
$593.00 - $609.80
52-week range:
$265.00 - $609.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
18.03x
P/B ratio:
21.86x
Volume:
214.1K
Avg. volume:
341K
1-year change:
93.72%
Market cap:
$13.7B
Revenue:
$180.1M
EPS (TTM):
-$13.01

Earnings Data

Next earnings date for MDGL
Feb 26
2026
Most recent earnings per share
-$5.08
Missed by $3.09
(Nov 4/2025)
Consensus Estimate
-$1.99
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MDGL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $310.7M -- -- -$0.46 --
11/04/2025 Q3 $247.7M $287.3M -$5.08 -$1.99 -$3.09
08/05/2025 Q2 $162.2M $212.8M -$1.90 -$3.53 $1.63
05/01/2025 Q1 $114.2M $137.3M -$3.32 -$3.79 $0.48
02/26/2025 Q4 $97.8M $103.3M -$2.71 -$4.12 $1.42
10/31/2024 Q3 $34.4M $62.2M -$4.92 -$6.91 $1.99
08/07/2024 Q2 $4.4M $14.6M -$7.10 -$7.66 $0.56
05/07/2024 Q1 -- -- -$7.38 -$6.39 -$0.98
02/28/2024 Q4 -- -- -$5.68 -$5.34 -$0.34
11/06/2023 Q3 -- -- -$5.34 -- --
08/08/2023 Q2 -- -- -$4.69 -- --
05/09/2023 Q1 -- -- -$4.23 -- --
02/23/2023 Q4 -- -- -$4.98 -- --
11/03/2022 Q3 -- -- -$4.75 -- --
08/04/2022 Q2 -- -- -$4.14 -- --
05/09/2022 Q1 -- -- -$3.36 -- --
02/24/2022 Q4 -- -- -$3.78 -- --
11/04/2021 Q3 -- -- -$3.79 -- --
08/05/2021 Q2 -- -- -$3.72 -- --
05/06/2021 Q1 -- -- -$3.32 -- --
02/25/2021 Q4 -- -- -$3.82 -- --
11/05/2020 Q3 -- -- -$3.75 -- --
08/06/2020 Q2 -- -- -$3.18 -- --
05/07/2020 Q1 -- -- -$2.34 -- --
02/26/2020 Q4 -- -- -$1.80 -- --
11/06/2019 Q3 -- -- -$1.39 -- --
08/07/2019 Q2 -- -- -$1.28 -- --
05/08/2019 Q1 -- -- -$0.98 -- --
02/27/2019 Q4 -- -- -$0.75 -- --
11/06/2018 Q3 -- -- -$0.56 -- --
08/07/2018 Q2 -- -- -$0.45 -- --
04/13/2018 Q1 -- -- -$0.45 -- --
12/31/2017 Q4 -- -- -$0.67 -- --
11/09/2017 Q3 -- -- -$0.68 -- --
08/10/2017 Q2 -- -- -$0.69 -- --
04/03/2017 Q1 -- -- -$0.50 -- --
12/31/2016 Q4 -- -- -$0.65 -- --
09/30/2016 Q3 -- -- -$1.34 -- --
06/30/2016 Q2 -- -- -$571.55 -- --
03/31/2016 Q1 -- -- -$340.20 -- --
12/31/2015 Q4 -- -- -$374.08 -- --

Madrigal Pharmaceuticals, Inc. Earnings Questions

  • How Much did Madrigal Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Madrigal Pharmaceuticals, Inc. reported $287.3M worth of top line sales in its most recent quarter.

  • Did Madrigal Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Madrigal Pharmaceuticals, Inc. announced earnings per share of -$5.08 which represents a miss of analyst forecast a -$1.99 per share.

  • Is Madrigal Pharmaceuticals, Inc. Profitable?

    Madrigal Pharmaceuticals, Inc. reported $268.8M that represents $11.96 per share over the last quarter.

  • What is the Analyst Consensus for Madrigal Pharmaceuticals, Inc. EPS Next Year?

    Madrigal Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$21.90 per share to -$23.47 per share next year representing a decrease of -49.12%.

  • When is Madrigal Pharmaceuticals, Inc.'s Earnings Date?

    Madrigal Pharmaceuticals, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock